Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial
John T Lear,1 Axel Hauschild,2 Eggert Stockfleth,3 Nicholas Squittieri,4 Nicole Basset-Seguin,5 Reinhard Dummer6 1Manchester Royal Infirmary, Manchester, UK; 2Klinik Für Dermatologie, Venerologie Und Allergologie Universitätsklinikum Schleswig-Holstein, Kiel, Germany; 3Universit&am...
| Main Authors: | , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2020-02-01
|
| Series: | Clinical, Cosmetic and Investigational Dermatology |
| Subjects: | |
| Online Access: | https://www.dovepress.com/efficacy-and-safety-of-sonidegib-in-adult-patients-with-nevoid-basal-c-peer-reviewed-article-CCID |
| _version_ | 1811286504205451264 |
|---|---|
| author | Lear JT Hauschild A Stockfleth E Squittieri N Basset-Seguin N Dummer R |
| author_facet | Lear JT Hauschild A Stockfleth E Squittieri N Basset-Seguin N Dummer R |
| author_sort | Lear JT |
| collection | DOAJ |
| description | John T Lear,1 Axel Hauschild,2 Eggert Stockfleth,3 Nicholas Squittieri,4 Nicole Basset-Seguin,5 Reinhard Dummer6 1Manchester Royal Infirmary, Manchester, UK; 2Klinik Für Dermatologie, Venerologie Und Allergologie Universitätsklinikum Schleswig-Holstein, Kiel, Germany; 3Universitätshautklinik Bochum, Bochum, Germany; 4Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA; 5Department of Dermatology, Hôpital Saint Louis, Paris, France; 6Skin Cancer Center University Hospital, Zürich, SwitzerlandCorrespondence: John T LearUniversity of Manchester, 46 Grafton Street, Manchester M13 9NT, UKTel +44 161 276 4173Fax +44 161 276 8881Email john.lear@srft.nhs.ukNevoid basal cell carcinoma syndrome (NBCCS), or Gorlin syndrome, is a rare hereditary disease characterized by the development of multiple cutaneous basal cell carcinomas (BCCs) from a young age.1 Loss-of-function germline mutations in the hedgehog-related patched 1 (PTCH1) tumor suppressor gene are the most common cause of NBCCS.1 The hedgehog signaling pathway plays a major role in embryonic development, and in adulthood, is involved in the renewal and maintenance of distinct tissues, including hair follicles, muscle stem cells, and gastric epithelium.2 Its abnormal activation is thought to drive the formation of both sporadic BCCs and those resulting from NBCCS.1 Patients with NBCCS inherit one inactive copy of PTCH1 and then acquire a “second-hit” mutation, resulting in hedgehog pathway activation and BCC formation.1 Mutations in Suppressor of fused (SUFU) or the PTCH1 homolog PTCH2 have also been found in a subset of patients meeting criteria for NBCCS.1,3 |
| first_indexed | 2024-04-13T03:01:11Z |
| format | Article |
| id | doaj.art-a2e4e127040044d894ed2c54e96472e5 |
| institution | Directory Open Access Journal |
| issn | 1178-7015 |
| language | English |
| last_indexed | 2024-04-13T03:01:11Z |
| publishDate | 2020-02-01 |
| publisher | Dove Medical Press |
| record_format | Article |
| series | Clinical, Cosmetic and Investigational Dermatology |
| spelling | doaj.art-a2e4e127040044d894ed2c54e96472e52022-12-22T03:05:26ZengDove Medical PressClinical, Cosmetic and Investigational Dermatology1178-70152020-02-01Volume 1311712151532Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized TrialLear JTHauschild AStockfleth ESquittieri NBasset-Seguin NDummer RJohn T Lear,1 Axel Hauschild,2 Eggert Stockfleth,3 Nicholas Squittieri,4 Nicole Basset-Seguin,5 Reinhard Dummer6 1Manchester Royal Infirmary, Manchester, UK; 2Klinik Für Dermatologie, Venerologie Und Allergologie Universitätsklinikum Schleswig-Holstein, Kiel, Germany; 3Universitätshautklinik Bochum, Bochum, Germany; 4Sun Pharmaceutical Industries, Inc., Princeton, NJ, USA; 5Department of Dermatology, Hôpital Saint Louis, Paris, France; 6Skin Cancer Center University Hospital, Zürich, SwitzerlandCorrespondence: John T LearUniversity of Manchester, 46 Grafton Street, Manchester M13 9NT, UKTel +44 161 276 4173Fax +44 161 276 8881Email john.lear@srft.nhs.ukNevoid basal cell carcinoma syndrome (NBCCS), or Gorlin syndrome, is a rare hereditary disease characterized by the development of multiple cutaneous basal cell carcinomas (BCCs) from a young age.1 Loss-of-function germline mutations in the hedgehog-related patched 1 (PTCH1) tumor suppressor gene are the most common cause of NBCCS.1 The hedgehog signaling pathway plays a major role in embryonic development, and in adulthood, is involved in the renewal and maintenance of distinct tissues, including hair follicles, muscle stem cells, and gastric epithelium.2 Its abnormal activation is thought to drive the formation of both sporadic BCCs and those resulting from NBCCS.1 Patients with NBCCS inherit one inactive copy of PTCH1 and then acquire a “second-hit” mutation, resulting in hedgehog pathway activation and BCC formation.1 Mutations in Suppressor of fused (SUFU) or the PTCH1 homolog PTCH2 have also been found in a subset of patients meeting criteria for NBCCS.1,3https://www.dovepress.com/efficacy-and-safety-of-sonidegib-in-adult-patients-with-nevoid-basal-c-peer-reviewed-article-CCIDsonidegibbasal cell carcinomanevoid basal cell carcinoma syndromegorlin syndrome |
| spellingShingle | Lear JT Hauschild A Stockfleth E Squittieri N Basset-Seguin N Dummer R Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial Clinical, Cosmetic and Investigational Dermatology sonidegib basal cell carcinoma nevoid basal cell carcinoma syndrome gorlin syndrome |
| title | Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title_full | Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title_fullStr | Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title_full_unstemmed | Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title_short | Efficacy and Safety of Sonidegib in Adult Patients with Nevoid Basal Cell Carcinoma Syndrome (Gorlin Syndrome): Results from a Phase 2, Double-Blind, Randomized Trial |
| title_sort | efficacy and safety of sonidegib in adult patients with nevoid basal cell carcinoma syndrome gorlin syndrome results from a phase 2 double blind randomized trial |
| topic | sonidegib basal cell carcinoma nevoid basal cell carcinoma syndrome gorlin syndrome |
| url | https://www.dovepress.com/efficacy-and-safety-of-sonidegib-in-adult-patients-with-nevoid-basal-c-peer-reviewed-article-CCID |
| work_keys_str_mv | AT learjt efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial AT hauschilda efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial AT stockflethe efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial AT squittierin efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial AT bassetseguinn efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial AT dummerr efficacyandsafetyofsonidegibinadultpatientswithnevoidbasalcellcarcinomasyndromegorlinsyndromeresultsfromaphase2doubleblindrandomizedtrial |